Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
BIOPOL

Biopol Chemicals Share Price

 

 

Biopol Chemicals live price: ₹109.3. It opened at ₹108 vs previous close ₹110; intraday high/low: ₹111/₹106.

Biopol Chemicals Performance

  • Today's Low
  • ₹106
  • Today's High
  • ₹111
  • 52 Week Low
  • ₹85
  • 52 Week High
  • ₹120
  • Open Price₹108
  • Previous Close₹110
  • Volume14,400
  • 50 DMA-
  • 100 DMA-
  • 200 DMA-

Biopol Chemicals Chart

Investment Returns

  • Over 1 Month + 12.1%
  • Over 3 Month + 1.2%
  • Over 6 Month + 1.2%
  • Over 1 Year + 1.2%

Smart Investing Starts Here Start SIP with Biopol Chemicals for Steady Growth!

Invest Now

Biopol Chemicals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 27.3
  • PEG Ratio
  • -
  • Market Cap Cr
  • 118
  • P/B Ratio
  • 5.3
  • Average True Range
  • 6.81
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • 3.22
  • RSI
  • 55.32
  • MFI
  • 61.9

Biopol Chemicals Financials

Biopol Chemicals Technicals

EMA & SMA

Current Price
₹109.30
-0.65 (-0.59%)
pointer
  • Bearish Moving Average 2
  • Bullish Moving Average 7
  • 20 Day
  • ₹105.17
  • 50 Day
  • -
  • 100 Day
  • -
  • 200 Day
  • -

Resistance and Support

108.58 Pivot Speed
  • R3 117.12
  • R2 114.03
  • R1 111.67
  • S1 106.22
  • S2 103.13
  • S3 100.77

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Biopol Chemicals Limited manufactures and distributes 66 specialty chemical products across silicones, emulsifiers, biochemicals, and polyelectrolytes. It operates 4 establishments in Gujarat and West Bengal, with 18,25,000 litres annual capacity, serving textiles, home care, agriculture, and industrial clients, including exports to Bangladesh.

Biopol Chemicals Ltd has an operating revenue of Rs. 93.92 Cr. on a trailing 12-month basis. An annual revenue growth of 93% is outstanding, Pre-tax margin of 12% is healthy, ROE of 32% is exceptional. The company has a reasonable debt to equity of 5%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 10% and 10% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around -0% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 56 which is a POOR score indicating inconsistency in earnings, a RS Rating of 71 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 76 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of D is close to being the worst. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Biopol Chemicals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-04-30 Audited Results

Biopol Chemicals F&O

Biopol Chemicals Shareholding Pattern

65.81%
9.3%
1.91%
7.67%
15.31%

Biopol Chemicals FAQs

Biopol Chemicals share price is ₹109 As on 26 April, 2026 | 11:36

The Market Cap of Biopol Chemicals is ₹118.1 Cr As on 26 April, 2026 | 11:36

The P/E ratio of Biopol Chemicals is 27.3 As on 26 April, 2026 | 11:36

The PB ratio of Biopol Chemicals is 5.3 As on 26 April, 2026 | 11:36

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23